These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30615342)

  • 1. PDPK1/RSK2 signaling pathway as the possible therapeutic target for multiple myeloma.
    Nihon Rinsho; 2016 Jul; 74 Suppl 5():180-4. PubMed ID: 30615342
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.
    Chinen Y; Kuroda J; Shimura Y; Nagoshi H; Kiyota M; Yamamoto-Sugitani M; Mizutani S; Sakamoto N; Ri M; Kawata E; Kobayashi T; Matsumoto Y; Horiike S; Iida S; Taniwaki M
    Cancer Res; 2014 Dec; 74(24):7418-29. PubMed ID: 25269480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
    Tatekawa S; Chinen Y; Ri M; Narita T; Shimura Y; Matsumura-Kimoto Y; Tsukamoto T; Kobayashi T; Kawata E; Uoshima N; Taki T; Taniwaki M; Handa H; Iida S; Kuroda J
    Br J Haematol; 2017 Aug; 178(4):534-546. PubMed ID: 28439875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
    Isa R; Horinaka M; Tsukamoto T; Mizuhara K; Fujibayashi Y; Taminishi-Katsuragawa Y; Okamoto H; Yasuda S; Kawaji-Kanayama Y; Matsumura-Kimoto Y; Mizutani S; Shimura Y; Taniwaki M; Sakai T; Kuroda J
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
    Maegawa S; Chinen Y; Shimura Y; Tanba K; Takimoto T; Mizuno Y; Matsumura-Kimoto Y; Kuwahara-Ota S; Tsukamoto T; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
    Exp Hematol; 2018 Mar; 59():72-81.e2. PubMed ID: 29287939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new and important relationship between miRNA-147a and PDPK1 in radiotherapy.
    Wang LJ; Li NN; Xu SJ; Zhang F; Hao MH; Yang XJ; Cai XH; Qiu PY; Ji HL; Xu P
    J Cell Biochem; 2018 Apr; 119(4):3519-3527. PubMed ID: 29144017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
    Kang S; Dong S; Gu TL; Guo A; Cohen MS; Lonial S; Khoury HJ; Fabbro D; Gilliland DG; Bergsagel PL; Taunton J; Polakiewicz RD; Chen J
    Cancer Cell; 2007 Sep; 12(3):201-14. PubMed ID: 17785202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.
    Yang C; Huang X; Liu H; Xiao F; Wei J; You L; Qian W
    Oncotarget; 2017 Jun; 8(24):39185-39197. PubMed ID: 28402933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1.
    Wang X; Qi M
    Pathol Res Pract; 2018 Nov; 214(11):1787-1793. PubMed ID: 30166214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
    Zhang H; Chen J; Zeng Z; Que W; Zhou L
    Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Notch signaling pathway and multiple myeloma].
    Gan ZH; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1380-3. PubMed ID: 19840488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.
    Mäemets-Allas K; Belitškin D; Jaks V
    Biochem Biophys Res Commun; 2016 May; 474(1):118-125. PubMed ID: 27103434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.
    Noh J; Wende AR; Olsen CD; Kim B; Bevins J; Zhu Y; Zhang QJ; Riehle C; Abel ED
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):297-305. PubMed ID: 26476238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.
    Sheffler DJ; Kroeze WK; Garcia BG; Deutch AY; Hufeisen SJ; Leahy P; Brüning JC; Roth BL
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4717-22. PubMed ID: 16537434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments.
    Hu J; Hu WX
    Cancer Lett; 2018 Feb; 414():214-221. PubMed ID: 29174802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling Pathways and Emerging Therapies in Multiple Myeloma.
    Ramakrishnan V; D'Souza A
    Curr Hematol Malig Rep; 2016 Apr; 11(2):156-64. PubMed ID: 26922744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormalities of signal transduction molecules in multiple myeloma].
    Sasaki M; Komatsu N
    Nihon Rinsho; 2015 Jan; 73(1):62-8. PubMed ID: 25626306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of pumpkin protein on expression of Notch signal in RPMI8226 myeloma cells].
    Liu TB; Yang P; Xie JM; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1012-5. PubMed ID: 25130819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influencing the Wnt signaling pathway in multiple myeloma.
    Kim Y; Reifenberger G; Lu D; Endo T; Carson DA; Gast SM; Meschenmoser K; Nowak M; Schmidt-Wolf IG
    Anticancer Res; 2011 Feb; 31(2):725-30. PubMed ID: 21378363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.